Economy · World

Theon in Exclusive Talks to Acquire HGH Systems in France

1 sourceFirst reported 1 month agoUpdated 1 month ago

AI summary: catch up in 20 seconds

Theon International is negotiating to acquire Steropes SAS, the parent company of HGH Systems.
The acquisition is valued at approximately 300 million euros and aims to strengthen Theon's position in the defense sector.
Theon plans to enhance its product portfolio with counter-drone systems and target recognition applications.
The acquisition will boost Theon's footprint in France, a key player in the global defense industry.
Theon continues to invest in new capabilities to meet growing international demand.

Generated by AI from the 1 sources below · always verify with the originals

AI summary: catch up in 20 seconds

Summarising the coverage…

Generated by AI from the 1 sources below · always verify with the originals

All coverage (1)

Sign in to join the discussion.

No comments yet. Be the first to join the discussion.

AI summary: catch up in 20 seconds

Theon International is negotiating to acquire Steropes SAS, the parent company of HGH Systems.
The acquisition is valued at approximately 300 million euros and aims to strengthen Theon's position in the defense sector.
Theon plans to enhance its product portfolio with counter-drone systems and target recognition applications.
The acquisition will boost Theon's footprint in France, a key player in the global defense industry.
Theon continues to invest in new capabilities to meet growing international demand.

Generated by AI from the 1 sources below · always verify with the originals